James Dean Watson
Independent DirectorMr. James Dean Watson, M.B.A, is Board of Directors & Observer of Genesis Therapeutics, Inc. Mr. Watson serves as Operating Partner at Andreessen Horowitz LLC. He also serves as Operating Partner at a16z Bio + Health. He also serves as an Independent Director of Scribe Therapeutics Inc. since July 2025, Director of RBL LLC and as Managing Director and Head of Private Equity at Burrill & Company. Prior to his current roles, Mr. Watson served as Chief Business Officer at Imago BioSciences, Inc. since November 2019. He served as Chief Business Officer at Carmot Therapeutics Inc. from 2020 to 2023, where he had also served as Head of Corporate Development and Finance from February 2020 to 2020. He served as Chief Business Officer & President of Sigilon Islet Cell Therapy of Sigilon Therapeutics, Inc. from 2018 to 2019 and was Chief Business Officer until 2018. He was Head of Corporate Development of PhaseRx, Inc. until May 16, 2017. He served as Chief Business Officer & Senior VP of Alvine Pharmaceuticals, Inc., which he joined in September 2011, where he led strategy, corporate development, new product planning and finance. He also served as the Chief Executive Officer of Burrill's Merchant Banking Group. Previously, he served as Senior Vice President at Incyte Genomics, where he headed the business development and marketing organizations and was also employed at Incyte Corporation. Before that, he served as a General Manager and Vice President of Business Development at Chemdex and as the CEO and Head of the San Francisco Office of The Wilkerson Group. He began his career with Eli Lilly & Company, where he gained operational experience in a variety of product development and commercially focused roles in the U.S. and the U.K. Mr. Watson received a Fulbright Scholarship and an M.B.A. from Indiana University, Bloomington and holds a B.A. in Economics from the University of Portsmouth.
Positions
- Company NameScribe Therapeutics Inc.Stock CodeSCTXPositionIndependent DirectorColleagues
- BLBenjamin L. OakesCo-Founder, President, CEO & Chairman
- DLDavid L. ParrotCFO & Treasurer
- SLSvetlana LucasChief Operating Officer
- JAJennifer A. DoudnaCo-Founder & Scientific Advisor
- BTBrett T. StaahlCo-Founder & VP of External Innovation
- JBJoshua BleharskiLead Independent Director
- BABehzad AghazadehIndependent Director
- CLCarl Lee GordonIndependent Director
